Warrant Liability (Details) - USD ($) |
3 Months Ended | ||||
|---|---|---|---|---|---|
Jul. 27, 2022 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Jan. 28, 2026 |
Dec. 31, 2025 |
|
| Warrant Liability [Line Items] | |||||
| Fair value of the warrants | $ 123,837 | $ 70,910 | |||
| Gain for the investor warrant | $ 52,927 | $ (209,294) | |||
| Warrant [Member] | |||||
| Warrant Liability [Line Items] | |||||
| Warrant to purchase ordinary shares (in Shares) | 4,530,000 | ||||
| Exercise price per share (in Dollars per share) | $ 4.49 | $ 1.2 | |||
| Warrant exercisable term | Jan. 26, 2028 | ||||
| X | ||||||||||
- Definition Date the warrants or rights are exercisable, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|